Oculo is pleased to announce its FDA registration and HIPAA compliance.
OPSM is taking steps to enhance patient care through multidisciplinary collaboration facilitated by the roll out of the well-known referral platform, Oculo.
The cost and challenge that Glaucoma detection and management poses to the world’s health systems can not be understated.
Leading Technology Companies Join Forces to Advance Patient Care by Integrating their Eye Care Platforms.
Parliamentary members, leaders in eye health and diabetes gathered at Parliament House in Canberra on 15 October to officially launch KeepSight.
Diabetes which affects about 1.7 million Australians, is the leading cause of preventable blindness Australia.
Here is where you will find who we are, why we do what we do, and all our latest news.